These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38917295)

  • 1. Healthcare provider and patient perspectives on the implementation of pharmacogenetic-guided treatment in routine clinical practice.
    Kaur G; Nwabufo CK
    Pharmacogenet Genomics; 2024 Sep; 34(7):236-245. PubMed ID: 38917295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Providers' perspectives on the clinical utility of pharmacogenomic testing in pediatric patients.
    Liko I; Lee YM; Stutzman DL; Blackmer AB; Deininger KM; Reynolds AM; Aquilante CL
    Pharmacogenomics; 2021 Apr; 22(5):263-274. PubMed ID: 33657875
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacogenetic testing in primary care practice: opinions of physicians, pharmacists and patients.
    Frigon MP; Blackburn MÈ; Dubois-Bouchard C; Gagnon AL; Tardif S; Tremblay K
    Pharmacogenomics; 2019 Jun; 20(8):589-598. PubMed ID: 31190623
    [No Abstract]   [Full Text] [Related]  

  • 4. Attitudes about pharmacogenomic testing vary by healthcare specialty.
    Preys CL; Blout Zawatsky CL; Massmann A; Heukelom JV; Green RC; Hajek C; Hickingbotham MR; Zoltick ES; Schultz A; Christensen KD
    Pharmacogenomics; 2023 Jul; 24(10):539-549. PubMed ID: 37458095
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary care physician experiences with integrated pharmacogenomic testing in a community health system.
    Lemke AA; Hutten Selkirk CG; Glaser NS; Sereika AW; Wake DT; Hulick PJ; Dunnenberger HM
    Per Med; 2017 Sep; 14(5):389-400. PubMed ID: 29754567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward Integration of Pharmacogenomic Tests into Daily Clinical Practice: A General Survey for Polish Healthcare Workers.
    Tafazoli A; Kitlas Golińska A; Mnich K; Amirabadizadeh A; Clark Marquez J; Miltyk W
    Med Sci Monit; 2023 Jun; 29():e940119. PubMed ID: 37303136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A qualitative approach to assess the opinion of physicians about the challenges and prospects of pharmacogenomic testing implementation in clinical practice in Greece.
    Koufaki MI; Patrinos GP; Vasileiou KZ
    Hum Genomics; 2024 Jul; 18(1):82. PubMed ID: 39030587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of primary care practitioners' attitudes and interest in pharmacogenomic testing.
    Smith DM; Namvar T; Brown RP; Springfield TB; Peshkin BN; Walsh RJ; Welsh JC; Levin B; Brandt N; Swain SM
    Pharmacogenomics; 2020 Oct; 21(15):1085-1094. PubMed ID: 32969759
    [No Abstract]   [Full Text] [Related]  

  • 9. Attitudes toward pharmacogenetics in patients undergoing
    Lee G; Varughese LA; Conway L; Stojinski C; Ashokkumar S; Monono K; Matthai W; Kolansky DM; Giri J; Tuteja S
    Per Med; 2022 Mar; 19(2):93-101. PubMed ID: 34984913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomic testing in oncology: a health system's approach to identify oncology provider perspectives.
    Bhatt M; Peshkin BN; Kazi S; Schwartz MD; Ashai N; Swain SM; Smith DM
    Pharmacogenomics; 2023 Nov; 24(16):859-870. PubMed ID: 37942634
    [No Abstract]   [Full Text] [Related]  

  • 11. Perspectives on the Clinical Use of Pharmacogenetic Testing in Late-Life Mental Healthcare: A Survey of the American Association of Geriatric Psychiatry Membership.
    Bousman CA; Oomen A; Jessel CD; Tampi RR; Forester BP; Eyre HA; Lavretsky H; Müller DJ
    Am J Geriatr Psychiatry; 2022 May; 30(5):560-571. PubMed ID: 34740522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment and clinical utility of pharmacogenomics by healthcare practitioners in North Carolina.
    Raccor BS; Thompson DK; Thomas C; Hill AK; Shields K; Alcala-Williams I; Cartrette T; Fasinu P; Al-Achi A
    Pharmacogenomics; 2021 Jan; 22(1):13-25. PubMed ID: 33356552
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary care and mental health providers' perceptions of implementation of pharmacogenetics testing for depression prescribing.
    Vest BM; Wray LO; Brady LA; Thase ME; Beehler GP; Chapman SR; Hull LE; Oslin DW
    BMC Psychiatry; 2020 Oct; 20(1):518. PubMed ID: 33115428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stakeholder perspectives of the clinical utility of pharmacogenomic testing in solid organ transplantation.
    Deininger KM; Tran JN; Tsunoda SM; Young GK; Lee YM; Anderson HD; Page Ii RL; Hirsch JD; Aquilante CL
    Pharmacogenomics; 2019 Dec; 20(18):1291-1302. PubMed ID: 31755847
    [No Abstract]   [Full Text] [Related]  

  • 15. PGx in psychiatry: Patients' knowledge, interest, and uncertainty management preferences in the context of pharmacogenomic testing.
    Kastrinos A; Campbell-Salome G; Shelton S; Peterson EB; Bylund CL
    Patient Educ Couns; 2021 Apr; 104(4):732-738. PubMed ID: 33414028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives of Pediatric Providers Regarding Clinical Use of Pharmacogenetics.
    Avello K; Bell M; Stein Q; Bares V; Landsverk M; Salyakina D; McCafferty-Fernandez J; Kingsmore S; Bedrick A; Bhojwani D; Hoyme HE
    S D Med; 2021 Jul; 74(7):294-301. PubMed ID: 34449988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient and healthcare professional acceptability of pharmacogenetic screening for DPYD and UGT1A1: A cross sectional survey.
    Glewis S; Krishnasamy M; Lingaratnam S; Harris S; Underhill C; Georgiou C; Warren M; Campbell R; IJzerman M; Fagery M; Campbell I; Martin JH; Tie J; Alexander M; Michael M
    Clin Transl Sci; 2023 Dec; 16(12):2700-2708. PubMed ID: 37877594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient characteristics, experiences and perceived value of pharmacogenetic testing from a single testing laboratory.
    Haga SB; Liu Y
    Pharmacogenomics; 2019 Jun; 20(8):581-587. PubMed ID: 31190624
    [No Abstract]   [Full Text] [Related]  

  • 19. Patients' perspectives of a pharmacist-provided clinical pharmacogenomics service.
    Martin JL; Lee YM; Corbin LW; Colson R; Aquilante CL
    Pharmacogenomics; 2022 Jun; 23(8):463-474. PubMed ID: 35469451
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacogenomic Testing for Major Depression: A Qualitative Study of the Perceptions of People with Lived Experience and Professional Stakeholders.
    Slomp C; Morris E; Edwards L; Hoens AM; Landry G; Riches L; Ridgway L; Bryan S; Austin J
    Can J Psychiatry; 2023 Jun; 68(6):436-452. PubMed ID: 36437757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.